Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07910201

The Impact of Osteosarcopenia on Falls, Kinesiophobia, and Quality of Life in Postmenopausal Women

Sponsor: Ayşe Ukbe Baykut

View on ClinicalTrials.gov

Summary

Osteosarcopenia (OSP) is defined as the coexistence of sarcopenia and osteoporosis/osteopenia. There is an intense and complex interaction-both mechanical (the "mechanostat" hypothesis) and biochemical (involving factors such as estrogen, testosterone, GH, IGF-1, IL-6, and osteocalcin)-between osteoporosis and sarcopenia. The general consensus is that sarcopenia leads to a reduction in bone mineral density. OSP is associated with significant physical disability, which poses a major threat to the future loss of independence. The increased propensity for falls-a consequence of sarcopenia-compounds the risk of fractures associated with osteoporosis, further exacerbating adverse health outcomes. Kinesiophobia, or the "fear of movement," is an excessive and irrational dread of performing physical movements or activities, stemming from the fear of a painful injury or the possibility of re-injury; this often leads to restrictions in activities of daily living. In a clinical setting, kinesiophobia is a critical issue that must be addressed to effectively manage a patient's disability, as it directly influences rehabilitation strategies. While there is some limited literature exploring the individual associations of osteoporosis and sarcopenia with kinesiophobia, no research has yet examined the relationship between osteosarcopenia and kinesiophobia. Our study aims to determine the impact of osteosarcopenia on kinesiophobia and quality of life in postmenopausal women.

Key Details

Gender

FEMALE

Age Range

45 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

109

Start Date

2025-01-02

Completion Date

2026-11-17

Last Updated

2026-11-02

Healthy Volunteers

No

Interventions

OTHER

Dual-energy x-ray absorptiometer

L1-L4 and L2-L4 regions, femoral neck T-scores, femoral neck BMD values, and body fat-muscle distribution will be evaluated. For appendicular skeletal muscle mass (ASM), the lean mass of the four extremities will be summed; an ASM value of \<15 kg will be considered indicative of sarcopenia. ASM will be adjusted for body size (ASM/height² and ASM/BMI).

Locations (1)

Ankara Bilkent City Hospital

Ankara, çankaya, Turkey (Türkiye)